Keryx Biopharmaceuticals Announces Appointment Of Jack Kaye, CPA, To Board Of Directors

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX - News) today announced the appointment of Jack Kaye, CPA, to the Company's Board of Directors.
MORE ON THIS TOPIC